Cargando…
Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (M(pro)) by using STD-NMR spectroscopy, in silico studies and antiviral assays
SARS-CoV-2 Main protease (M(pro)) is a well-known drug target against SARS-CoV-2 infection. Identification of M(pro) inhibitors is vigorously pursued due to its crucial role in viral replication. The present study was aimed to identify M(pro) inhibitors via repurposing of US-FDA approved drugs by ST...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896891/ https://www.ncbi.nlm.nih.gov/pubmed/36740128 http://dx.doi.org/10.1016/j.ijbiomac.2023.123540 |